However, they will not automatically move into Category 1, where the agency has stated it would generally not take action against compounders
Key gaps include: No large-scale randomised controlled trials in humans the evidence basis for clinical use is extrapolated from animal data and small pilot studies No long-term safety data effects beyond 1216 weeks are not well characterised Variable results in human sleep trials some early human studies showed modest or inconsistent effects on sleep architecture compared to animal data, suggesting the translation may not be linear No FDA approval DSIP is not approved for any therapeutic use in the United States Stability concerns DSIP degrades relatively quickly in circulation
10.1016/j.foodchem.2019.125124 134 MaramaldiG.TogniS.PaginI.GiacomelliL.CattaneoR.EggenhffnerR.et al (2016)
People's Liberation Army 42 (06), 553558
Ethics declarations Ethics approval and consent to participate All procedures described herein were approved by the Institutional Review Board for the Protection of Human Subjects of Baylor University (Protocol # 7920244) and Research Ethical Review Committee of Kyowa Hakko Kirin Co., Ltd
Ablation of the inammatory enzyme myeloperoxidase mitigates features of Parkinsons disease in mice
